NIH-funded research R01 grant

Platelets and abdominal aortic aneurysm growth

Official title: Platelets as Biosensors and Mediators of Aortic Aneurysm Growth

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-11109654 · Data updated 2026-11-12

Looking at whether blocking a specific platelet receptor can help slow aneurysm growth in older adults with abdominal aortic aneurysms.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startJuly 1, 2021
Project endJune 30, 2027
Funding year2025
Award (this year)$489,364
NIH project number5R01HL158801-05
Project IDNIH-11109654 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults (about 65 and older) who have an unruptured abdominal aortic aneurysm and can provide blood samples or attend visits at the study site.

Less likely to help

People without an abdominal aortic aneurysm, those with a ruptured aneurysm requiring emergency care, or patients whose aneurysm is unrelated to platelet activity are unlikely to benefit from this project.

What this research studies

Researchers will work with platelets taken from people with abdominal aortic aneurysms and expose them to blood-flow conditions that mimic aneurysms. They will study a newly identified receptor on the platelet surface that appears to make platelets overactive and release proteins linked to faster aneurysm growth. Lab tests will compare how blocking that receptor works versus aspirin and other antiplatelet approaches. The team will also look for platelet-derived proteins in blood that could act as biomarkers to tell who has a fast-growing aneurysm.

Why it matters

Potential benefit: If successful, this research could produce the first drug approach to slow aneurysm growth and blood tests to identify patients at high risk of rapid enlargement.

How similar studies have gone: Prior work suggests aspirin can partially slow aneurysm growth, but targeting the platelet olfactory receptor and using platelet proteins as biomarkers is a new and untested approach.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Cameron, Scott James — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Cameron, Scott James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.